NASDAQ:BRTX | Free Cash Flow | BioRestorative Therapies, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.81M
2025-12-31-$2.42M$79,669.00-$2.49M
2025-03-31-$2.78M$36,400.00-$2.82M
2024-12-31-$2.35M$12,434.00-$2.36M
2024-03-31-$2.32M
2023-12-31-$1.59M$70,024.00-$1.66M
2023-03-31-$2.38M$60,022.00-$2.44M
2022-12-31-$1.62M$42,581.00-$1.66M
2022-03-31-$1.59M$109,573.00-$1.7M
2021-12-31-$1.15M
2021-03-31-$813,701.00
2020-12-31-$572,120.00
2020-03-31-$448,646.00
2019-12-31-$1.81M$0.00-$1.81M
2019-03-31-$1.98M
2018-12-31-$1.55M$0.00-$1.55M
2018-03-31-$1.16M
2017-12-31-$1.36M
2017-03-31-$1.22M
2016-12-31-$1.06M$6,822.00-$1.07M
2016-03-31-$1.72M$89,865.00-$1.81M
2015-12-31-$1.05M$47,603.00-$1.1M
2015-03-31-$674,778.00$92,169.00-$766,947.00
2014-12-31-$634,258.00$166,850.00-$801,108.00
2014-03-31-$806,728.00$0.00-$806,728.00
2013-12-31-$763,753.00$11,160.00-$774,913.00
2013-03-31-$771,773.00$0.00-$771,773.00
2012-12-31-$1.08M$0.00-$1.08M
2012-03-31-$393,895.00$0.00-$393,895.00
2011-12-31-$1.12M$0.00-$1.12M
2011-03-31-$849,911.00$6,891.00-$856,802.00
2010-12-31-$392,909.00-$64,494.00-$457,403.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.79M$116,069.00-$10.91M
2024-12-31-$8.23M$106,189.00-$8.34M
2023-12-31-$6.43M$171,043.00-$6.6M
2022-12-31-$5.91M$265,223.00-$6.18M
2021-12-31-$3.33M$30,658.00-$3.36M
2020-12-31-$1.96M
2019-12-31-$6.92M$35,631.00-$6.95M
2018-12-31-$5.1M$12,869.00-$5.12M
2017-12-31-$3.85M$3,617.00-$3.86M
2016-12-31-$5M$188,764.00-$5.19M
2015-12-31-$3.12M$408,069.00-$3.53M
2014-12-31-$3.23M$168,376.00-$3.4M
2013-12-31-$2.67M$11,160.00-$2.68M
2012-12-31-$3.18M$2,533.00-$3.19M
2011-12-31-$2.81M$17,772.00-$2.83M
2010-12-31-$729,218.00$45,383.00-$774,601.00